GlassScriptPhysician profile
Kimberly Ann Griffith
NPI 1033541123
$1,664.48
in general payments reported to CMS, 2019-2025
20 companies · $416 in 2025
The $416 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $303 · 2022: $219 · 2023: $445 · 2024: $281 · 2025: $416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,143.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $203.81 | 2022-2025 | Nucala, Benlysta |
| Ipsen Biopharmaceuticals, INC | $132.52 | 2025 | Iqirvo |
| Inspire Medical Systems, INC. | $128.25 | 2025 | Inspire |
| Esperion Therapeutics, INC. | $106.29 | 2021 | |
| Amgen INC. | $103.32 | 2021 | |
| Boston Scientific Corporation | $98.69 | 2021-2023 | Spyglass |
| Bayer Healthcare Pharmaceuticals INC. | $97.99 | 2023 | |
| Sage Therapeutics, LLC | $89.73 | 2025 | |
| Abbvie INC. | $78.44 | 2021-2024 | |
| Nevro Corp. | $78.24 | 2024 | Senza |
| Sanofi-Aventis U.S. LLC | $77.88 | 2024 | |
| Axonics, INC. | $75.44 | 2023 | Axonics |
| Shield Therapeutics INC | $66.88 | 2023 | Accrufer |
| Biogen, INC. | $64.57 | 2023 | |
| Abbott Laboratories | $62.34 | 2024 | Proclaim |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $56.95 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $51.42 | 2022 | |
| Lilly USA, LLC | $43.52 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $26.47 | 2024 | Lifevest |
| Genzyme Corporation | $21.73 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Griffith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.